Close Menu

aneuploidy

NEW YORK (GenomeWeb News) – With the arrival over the past year of several new prenatal genetic diagnostic tests and recent advances in sequencing the fetal genome, genomic medicine has begun to show how it may be used to diagnose diseases in fetuses early in pregnancy and with high accuracy, but

The story has been updated to include comments by Sequenom.
NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said that Sequenom's motion for a preliminary injunction against it has been denied by a federal court.

Belgian molecular diagnostics firm Multiplicom said this week that it has been awarded €200,000 ($250,000) from the Flemish agency for Innovation by Science and Technology to develop a blood-based non-invasive molecular diagnostic test for fetal aneuploidy.

NEW YORK (GenomeWeb News) – Belgian molecular diagnostics firm Multiplicom today said it has been awarded €200,000 ($250,000) to develop a blood-based non-invasive fetal aneuploidy test.

NEW YORK (GenomeWeb News) – Coventry Health Care National Network has terminated its coverage agreement with Sequenom covering the MaterniT21 Plus test, just one week after the agreement was announced, the San Diego-based molecular diagnostics firm said after the close of the market on Thursday.

NEW YORK (GenomeWeb News) – Sequenom today said that health insurance provider Coventry Health Care National Network will provide coverage for its T21 test.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today announced a partnership with Laboratory Corporation of America and Integrated Genetics to make its T21 test available in the US and Canada.

NEW YORK (GenomeWeb News) – Fluidigm today announced its collaboration with Novartis to develop a non-invasive fetal diagnostic test has ended.

Researchers from Radboud University Nijmegen Medical Center have published a method of non-invasive prenatal diagnosis using massively parallel sequencing-by-ligation on the Life Technologies SOLiD 4 platform.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Sequenom today announced an expanded agreement with healthcare cost management firm MultiPlan to include the MaterniT21 Plus LDT test for fetal aneuploidies.

Pages

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.